INOVIO (NASDAQ: INO) said the U.S. Food and Drug Administration has accepted its Biologics License Application for INO-3107, ...

INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today ...

Ino and Sakura’s rivalry is frequently criticized for being shallow and revolving around a boy who (at least at the time) wasn’t even interested in them. But while Sasuke played a major role in the ...

Inovio Pharmaceuticals (INO) reported a disappointing 3Q25 with a GAAP EPS loss of -$0.87, missing consensus by $0.45 and triggering a 12% stock slide. INO ended the quarter with $50.8 million in cash ...

Inovio Pharmaceuticals Inc. Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with ...

Investing.com -- Inovio Pharmaceuticals Inc (NASDAQ:INO) stock plunged 21% Monday after the FDA raised concerns about the company’s accelerated approval pathway for its RRP treatment candidate.

The work comes from Instagram courtesy of shiogane_sama. The fan, who is known for cosplaying all sorts of anime heroines, felt it was time to shine a light on Ino. And as you can see below, the ...